论文部分内容阅读
作者经过实践认为闭经妇女的诱发排卵药物的选择可根据两点:(1)应用孕酮后有无撤退性出血;(2)有无泌乳。在有撤退性出血及有或无泌乳的患者,诱发排卵的首选药物是克罗米芬。无撤退性出血又无泌乳患者应用人类绝经期促性腺激素(H.M.G),假使有泌乳,可给予溴素角隐亭。共观察76例原发和继发闭经并希望生育患者用克罗米芬,溴素角隐亭或人类绝经促性腺激素(H.M.G)治疗。其中71例接受了克罗米芬治疗,39人(55％)排卵。
After practice, the author believes that amenorrhea women induced ovulation induction drug selection can be based on two points: (1) after the application of progesterone with or without withdrawal bleeding; (2) with or without lactation. In patients with withdrawal bleeding and with or without lactation, the preferred drug for ovulation induction is clomiphene. Non-withdrawal bleeding without lactation in patients with human menopausal gonadotropin (H.M.G), if lactation, may be given bromocriptine. A total of 76 patients with primary and secondary amenorrhoea were observed and treated with clomiphene citrate, cromolyn sodium bromide or human H. pylori (H.M.G). Of these, 71 received clomiphene and 39 (55%) ovulation.